TP53 and B-cell chronic lymphocytic leukemia: It has been suggested that TIGAR inhibits tumor growth by acting in a similar manner to the tumor suppressor P53. López-Guerra et al. found that high expression of TIGAR was positively correlated with chronic lymphocytic leukemia (CLL) sensitivity to Fludarabine, which can induce apoptosis [22].